Despite the extensive molecular and functional characterization of EGFR and a continuing effort in pursuing anti-EGFR cancer therapies, the molecular mechanism underlying the regulation/dysregulation of EGFR expression remains poorly explored. The gene discussed is EGFR; the disease is cancer.